Technical Analysis for OPTI - Optibiotix Health Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Reversal New Lows Setup | Bearish Swing Setup | 0.00% | |
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Narrow Range Bar | Range Contraction | -1.39% | |
| Doji - Bullish? | Reversal | -1.39% | |
| Wide Bands | Range Expansion | -1.39% | |
| Oversold Stochastic | Weakness | -1.39% | |
| New Downtrend | Bearish | -1.39% | |
| NR7 | Range Contraction | -1.39% |
| Alert | Time |
|---|---|
| 3x Volume Pace | about 21 hours ago |
| 2x Volume Pace | about 21 hours ago |
| 1.5x Volume Pace | about 21 hours ago |
| Fell Below Previous Day's Low | about 22 hours ago |
| Down 2% | about 22 hours ago |
Get a Trading Sidekick!
Optibiotix Health Plc Description
Optibiotix Health Plc is a life sciences company developing a range of products to modify the human microbiome. The Company's principal activity is research and development into microbiome modulators. It operates in UK segment. The Company has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is operated by its OptiScreen and OptiBiotic platform technologies designed to identify metabolic pathways and compounds that impact on human physiology. Its Optiscreen is a screening and optimization technology platform designed to identify microbes within the human microbiome with metabolic pathways, which can interact with human physiological processes. Its OptiBiotic is a platform technology, which generates compounds and screens them for their ability to modulate the human microbiome and its microbial end products. Its platforms are applicable across a range of other human diseases.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Energy Health Science Life Sciences Disease Pipe Diseases Biology Platform Technology Microbiology Bacteriology Clinical Pathology End Products Energy Harvest Environmental Microbiology Human Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 43.495 |
| 52 Week Low | 5.57 |
| Average Volume | 279,694 |
| 200-Day Moving Average | 25.43 |
| 50-Day Moving Average | 22.57 |
| 20-Day Moving Average | 19.57 |
| 10-Day Moving Average | 18.75 |
| Average True Range | 1.00 |
| RSI (14) | 27.01 |
| ADX | 26.65 |
| +DI | 14.60 |
| -DI | 29.14 |
| Chandelier Exit (Long, 3 ATRs) | 22.01 |
| Chandelier Exit (Short, 3 ATRs) | 20.57 |
| Upper Bollinger Bands | 22.27 |
| Lower Bollinger Band | 16.86 |
| Percent B (%b) | 0.16 |
| BandWidth | 27.66 |
| MACD Line | -1.45 |
| MACD Signal Line | -1.41 |
| MACD Histogram | -0.0394 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 18.91 | ||||
| Resistance 3 (R3) | 18.98 | 18.66 | 18.71 | ||
| Resistance 2 (R2) | 18.66 | 18.37 | 18.63 | 18.65 | |
| Resistance 1 (R1) | 18.21 | 18.19 | 18.05 | 18.14 | 18.59 |
| Pivot Point | 17.89 | 17.89 | 17.81 | 17.86 | 17.89 |
| Support 1 (S1) | 17.44 | 17.60 | 17.28 | 17.36 | 16.91 |
| Support 2 (S2) | 17.12 | 17.42 | 17.09 | 16.85 | |
| Support 3 (S3) | 16.66 | 17.12 | 16.79 | ||
| Support 4 (S4) | 16.59 |
